Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Sarcoma 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Castration-resistant Prostate Cancer 2 Urologic Neoplasms 1 Stomach Neoplasms 1 Osteosarcoma 1 Melanoma 1 Lymphatic Metastasis 1 Ependymoma 1 Colonic Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Breast Neoplasms 1 Bone Neoplasms 1 Adenocarcinoma 1 Abdominal Neoplasms 1

Interventions

Oxaliplatin 46 Gemcitabine 45 Fluorouracil 40 Capecitabine 31 pembrolizumab 30 Leucovorin 29 Docetaxel 27 Cisplatin 25 Paclitaxel 23 Irinotecan 18 Carboplatin 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 17 Radiotherapy 16 Pemetrexed 15 Albumin-Bound Paclitaxel 15 Nivolumab 13 Ramucirumab 11 Cyclophosphamide 11 Drug Therapy 9 Trastuzumab 8 Erlotinib Hydrochloride 8 zolbetuximab 7 Taxes 7 Radiosurgery 7 trastuzumab deruxtecan 6 cemiplimab 6 Blood Specimen Collection 6 regorafenib 5 durvalumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Metastasectomy × Clear all

NCT06121700 2023-11-08

Miracle-G

Fudan University

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡